These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 7875058)

  • 21. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H; Galanakis N
    Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosa.
    Giamarellou H; Daphnis E; Dendrinos C; Daikos GK
    Drugs Exp Clin Res; 1985; 11(5):351-6. PubMed ID: 2941264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
    Parras F; Torroba L; Buzón L; Martínez-Beltrán J; Loza E; Baquero F
    Enferm Infecc Microbiol Clin; 1989 May; 7(5):261-5. PubMed ID: 2490722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin: a study of usage in pedal infections with case reports.
    Notari MA; Mittler BE
    J Foot Surg; 1989; 28(6):521-3. PubMed ID: 2630590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
    Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ
    Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C; Li J; Hou J; Guo M; Zhang Y; Chen Y
    Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
    Petrikkos G; Giamarellou H; Tsagaraki C; Pefanis A
    J Chemother; 1995 Jun; 7 Suppl 2():161-4. PubMed ID: 8622106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ
    Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of ciprofloxacin therapy in urinary and respiratory tract infections].
    Polubiec A; Jórasz I; Kłos K; Ozarek-Medyńska T; Pietrzak J; Starzyńska R; Stepka K
    Pol Tyg Lek; 1990 Jan 22-29; 45(4-5):85-9. PubMed ID: 2395758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral ciprofloxacin in refractory gram-negative bacillary infections.
    Bryant RE; Hartstein AI
    Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.
    Chayakul P; Krisanapan S; Kalnauwakul S
    J Med Assoc Thai; 1993 Jan; 76(1):35-40. PubMed ID: 8228692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods.
    Valtonen V; Karppinen L; Kariniemi AL
    Scand J Infect Dis Suppl; 1989; 60():79-83. PubMed ID: 2547245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.